Posted on 12월 23, 201912/23/19
ICER’s Unsupported Price Increase Assessment
Posted on 12월 23, 201912/23/19
How to Maximize the Value of New Advances in Oncology
Posted on 11월 21, 201911/21/19
Decoding ICER: Successful Pharma Engagement with ICER for U.S. HTA Review
Posted on 11월 15, 201911/15/19
Integrated Delivery Networks: Learning to Engage With a New Customer With Very Different Needs
Posted on 11월 1, 201911/1/19
Global Biosimilar Competitor Assessment – Who Wins in Biosimilar Access and Why?
Posted on 10월 23, 201910/23/19
Considerations for Compliance with the EU General Data Protection Regulation (GDPR)
Posted on 10월 9, 201910/9/19
Navigating Channel Distribution in a New (and more complex) Biopharma World
Posted on 9월 9, 20199/9/19
340B Drug Pricing: Challenges and Best Practices
Posted on 8월 13, 20198/13/19
Patient-Centered Engagement: Wrapping Value Around Life Science Services
Posted on 6월 28, 20196/28/19